N Praschak-Rieder
Biographic Data
| ID | 7637405 |
|---|---|
| NAME | N Praschak-Rieder |
| GIVEN NAMES | N |
| FAMILY NAME | Praschak-Rieder |
| SIGNATURE | PRASCHAK-RIEDER N |
| AFFILIATIONS | Medical University of Vienna |
| ORCID | 0000-0001-7617-2835 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Ketamine for negative and depressive symptoms in schizophrenia
Schizophrenia (SCZ) is a severe psychiatric condition characterized by positive symptoms such as hallucinations or delusions, as well as negative symptoms such as apathy, anhedonia and avolition. Given their chronic nature and limited response to current treatments, managing negative symptoms is a significant challenge for healthcare providers. Furthermore, many individuals with SCZ suffer from depressive symptoms during the course of their illne…
Case report
The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portra…
No prominent works on this page.
Case report
The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portra…
Ketamine for negative and depressive symptoms in schizophrenia
Schizophrenia (SCZ) is a severe psychiatric condition characterized by positive symptoms such as hallucinations or delusions, as well as negative symptoms such as apathy, anhedonia and avolition. Given their chronic nature and limited response to current treatments, managing negative symptoms is a significant challenge for healthcare providers. Furthermore, many individuals with SCZ suffer from depressive symptoms during the course of their illne…
Anesthesia (1 work) · Anesthesia and Sedative Agents (1 work) · Anhedonia (1 work) · Anticholinergic (1 work) · Antidepressant (1 work) · Antipsychotic (1 work) · Benzodiazepine (1 work) · Clozapine (1 work) · Delirium (1 work) · Depression (economics (1 work)